-
Diagnostics World News | 23andMe released two new medication insight reports last week as part of the company’s 23andMe+ membership. The two new reports provide medication insights on how a person’s CYP2C19 metabolizer profile may impact therapies with citalopram, a blood thinner, and clopidogrel, an antidepressant.
May 20, 2021
-
Diagnostics World News | When patients are battling any kind of infection, the focus is invariably more on the bug in their system than their immune response to its presence. Yet overactivation of the body’s infection-fighting processes is what leads to conditions like sepsis—a leading cause of death in hospitals.
May 19, 2021
-
Diagnostics World News | The Institute for Genomic Health at Mount Sinai Health System is launching pilot programs in the clinic based on discoveries from genomic research to evaluate their real-world utility. Where genomics data proves useful, the necessary infrastructure then gets built in terms of educating medical professionals and creating navigational paths for patients to bring that information to bear in clinical decision-making.
May 18, 2021
-
Diagnostics World News | TNF-α inhibitors have been crucial in many diseases including IBD, psoriasis, cancer, and Alzheimer’s disease, among others. What exactly are we measuring to determine drug effectiveness and how can we, as clinicians, determine if these drugs are improving patient’s symptoms?
May 13, 2021
-
Diagnostics World News | In a research letter published last week in JAMA, St Jude Children’s Research Hospital researchers reported early findings tracking asymptomatic COVID-19 among vaccinated healthcare workers. The findings will inform both individual vaccination plans as well as institutional screening and testing programs.
May 12, 2021
-
Diagnostics World News | Ginkgo Bioworks has added a collaboration with Quest Diagnostics to its existing network of COVID-19 testing labs. Quest Diagnostics has capacity to perform 300,000 COVID-19 PCR tests a day; the added capacity will give Ginkgo the capacity to test all 60 million US students, teachers and staff, every week.
May 7, 2021
-
Diagnostics World News | Quidel and Abbott have introduced at-home COVID-19 antigen tests that do not require a prescription and deliver results in just minutes. They are also completely independent of doctor oversight or reporting of results.
May 6, 2021
-
Diagnostics World News | New sequencing project looks at developmental differences, Castle Biosciences to acquire Myriad’s myPath, AI tools for cystic fibrosis detection, updates in COVID-19 diagnostics, and more new products and updates from around the industry.
May 3, 2021
-
Diagnostics World News | New funding for rapid, easy-to-use PCR and near-patient sepsis diagnostics; a seed round for preconception genetic risk modeling; and a new business for Qlucore: cancer diagnostics.
Apr 29, 2021
-
Diagnostics World News | Passive activity tracking could one day be used as a primary vital sign along with measures of body temperature, pulse, respiratory rate, and blood pressure. The “activity index” (Ai) of patients could be valuable to physicians when evaluating patients in the emergency room with vague complaints and deciding on degree of diagnostic testing.
Apr 26, 2021
-
Diagnostics World News | At the beginning of 2020, Aegis Sciences was a Nashville-based national toxicology lab, with a small biopharma lab. Today, they can do more than 110,000 COVID-19 tests per day. It’s been a busy year.
Apr 21, 2021
-
Diagnostics World News | Sema4 has launched a strategic partnership with NorthShore University HealthSystem announcing the availability of a system-wide data-driven genomics program that uses predictive analytics to help clinicians and patients prevent, detect, and treat diseases at an early stage.
Apr 19, 2021
-
Diagnostics World News | A UK company has released Drug Ranking Using Machine Learning (DRUML), an open-source ensemble of predictive models trained for drugs with different modes of action that can help clinicians pick the most appropriate cancer drugs for individual patients from among most (412 of 659) of the options now available.
Apr 14, 2021
-
Diagnostics World News | A new study led by University of Minnesota Medical School researchers suggests that Pap test samples and cervical swabs may be a useful source of tumor-specific biomarkers for ovarian cancer, and the group sees potential for the development of an early detection test.
Apr 13, 2021
-
Diagnostics World News | A year into COVID-19, we see that it has cast an unexpected spotlight on digital pathology. It has accelerated adoption as laboratories’ ability to operate has increasingly become tied to their digital footprint. In doing so, it has also laid the foundation for laboratories to realize the benefits of the digital transformation beyond remote work, positioning them to meet future challenges and capitalize on the opportunity ahead.
Apr 9, 2021